Promising Phase 3 Results for Cefepime-Taniborbactam in Treating Complicated UTIs
MALVERN, PA — Venatorx Pharmaceuticals, Melinta Therapeutics LLC, and the Menarini Group recently celebrated a significant medical breakthrough with the publication of the CERTAIN-1 Phase 3 clinical study results in …
Promising Phase 3 Results for Cefepime-Taniborbactam in Treating Complicated UTIs Read More